TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004
TCL Archive The Centers for Medicare and Medicaid Services and NCI said they are developing a Memorandum of Understanding to address how the agencies can work together to improve the process for making coverage decisions for cancer therapy and diagnosis. June 11, 2004
TCL Archive ODAC Nixes Sanofi’s VTE Drug in 14-1 Vote, Setting High Bar For Adjunctive Therapies June 22, 2012
TCL Archive DCT Board Approves Recommendations For Clinical Trials; Some Controversial November 9, 1979
